This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2001 Nov-Dec;33(7-8):3621-3.

doi: 10.1016/s0041-1345(01)02558-1.

Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

C Jung¹, E Engelmann, K Borner, G Offermann

Affiliations

Affiliation

¹ Medizinische Klinik IV, Institut für Infektionsmedizin, Institut für Klinische Chemie und Pathobiochemie, Universitätsklinikum Benjamin Franklin, Freie Universität, Berlin, Germany.

PMID: 11750538
DOI: 10.1016/s0041-1345(01)02558-1

Clinical Trial

Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

C Jung et al. Transplant Proc. 2001 Nov-Dec.

. 2001 Nov-Dec;33(7-8):3621-3.

doi: 10.1016/s0041-1345(01)02558-1.

Authors

C Jung¹, E Engelmann, K Borner, G Offermann

Affiliation

¹ Medizinische Klinik IV, Institut für Infektionsmedizin, Institut für Klinische Chemie und Pathobiochemie, Universitätsklinikum Benjamin Franklin, Freie Universität, Berlin, Germany.

PMID: 11750538
DOI: 10.1016/s0041-1345(01)02558-1

No abstract available

PubMed Disclaimer

Similar articles

Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients.
Chak WL, Choi KS, Wong KM, Chan YH, Chau KF, Li CS. Chak WL, et al. Transplant Proc. 2003 Feb;35(1):280-1. doi: 10.1016/s0041-1345(02)03892-7. Transplant Proc. 2003. PMID: 12591399 No abstract available.
Ganciclovir prophylaxis of cytomegalovirus disease.
Conti DJ, Shen G, Singh T, Isenberg A, Freed BM. Conti DJ, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):804-6. doi: 10.1016/s0041-1345(96)00141-8. Transplant Proc. 1997. PMID: 9123534 Clinical Trial. No abstract available.
Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.
Mauskopf JA, Richter A, Annemans L, Maclaine G. Mauskopf JA, et al. Pharmacoeconomics. 2000 Sep;18(3):239-51. doi: 10.2165/00019053-200018030-00004. Pharmacoeconomics. 2000. PMID: 11147391
Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
Singh N. Singh N. Clin Infect Dis. 2001 Mar 1;32(5):742-51. doi: 10.1086/319225. Epub 2001 Feb 20. Clin Infect Dis. 2001. PMID: 11229841 Review.
Costs and consequences of cytomegalovirus disease.
Schnitzler MA. Schnitzler MA. Am J Health Syst Pharm. 2003 Dec 1;60(23 Suppl 8):S5-8. doi: 10.1093/ajhp/60.suppl_8.S5. Am J Health Syst Pharm. 2003. PMID: 14686228 Review.

See all similar articles

Cited by

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW, Michael M, Ladhani M, Webster AC, Strippoli GF, Craig JC, Hodson EM. Vernooij RW, et al. Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5. Cochrane Database Syst Rev. 2024. PMID: 38700045 Free PMC article.
A Systematic Review and Meta-analysis of Prophylactic versus Pre-emptive Strategies for Preventing Cytomegalovirus Infection in Renal Transplant Recipients.
Rawal BB, Shadrou S, Abubacker F, Ghahramani N. Rawal BB, et al. Int J Organ Transplant Med. 2012;3(1):10-7. Int J Organ Transplant Med. 2012. PMID: 25013618 Free PMC article.
Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study.
Kamar N, Kaminski H, Masset C, Castagné C, Tournaire G, Bourge X, Bensimon L, Naja M, Degroote S, Durand-Zaleski I, Legendre C. Kamar N, et al. Transpl Int. 2025 May 19;38:14342. doi: 10.3389/ti.2025.14342. eCollection 2025. Transpl Int. 2025. PMID: 40458544 Free PMC article.
Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient.
Hemmersbach-Miller M, Alexander BD, Pieper CF, Schmader KE. Hemmersbach-Miller M, et al. Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):455-463. doi: 10.1007/s10096-019-03744-3. Epub 2019 Nov 22. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31758441 Free PMC article.
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.
Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD. Atabani SF, et al. Am J Transplant. 2012 Sep;12(9):2457-64. doi: 10.1111/j.1600-6143.2012.04087.x. Epub 2012 May 17. Am J Transplant. 2012. PMID: 22594993 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information